c-Myc modulation & acetylation is a key HDAC inhibitor target in cancer.
Clin Cancer Res. 2016 Jun 29. pii: clincanres.2388.2015. [Epub ahead of print]
Angela N, Carafa V, Conte M, Tambaro FP, Abbondanza C, Martens JH, Nees M, Benedetti R, Pallavicini I, Minucci S, Garcia-Manero G, Iovino F, Lania G, Ingenito C, Belsito Petrizzi V, Stunnenberg HG, Altucci L.